Literature DB >> 18303474

MicroRNAs.

Muller Fabbri1, Carlo M Croce, George A Calin.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs with regulatory functions, which play an important role in many human diseases, including cancer. An emerging number of studies show that miRNAs can act either as oncogenes or as tumor suppressor genes or sometimes as both. Germline, somatic mutations and polymorphisms can contribute to cancer predisposition. miRNA expression levels have diagnostic and prognostic implications, and their roles as anticancer therapeutic agents is promising and currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303474     DOI: 10.1097/PPO.0b013e318164145e

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  96 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  Applications of microRNA in cancer: Exploring the advantages of miRNA.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

3.  Modified least-variant set normalization for miRNA microarray.

Authors:  Chen Suo; Agus Salim; Kee-Seng Chia; Yudi Pawitan; Stefano Calza
Journal:  RNA       Date:  2010-10-27       Impact factor: 4.942

4.  Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population.

Authors:  Bin Yang; Jun Long Zhang; Yun Ying Shi; Dong Dong Li; Jie Chen; Zhuo Chun Huang; Bei Cai; Xing Bo Song; Li Xin Li; Bin Wu Ying; Lan Lan Wang
Journal:  Mol Biol Rep       Date:  2010-12-22       Impact factor: 2.316

5.  MicroRNAs: the primary cause or a determinant of progression in leukemia?

Authors:  Marina Bousquet; Harvey F Lodish
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

6.  MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.

Authors:  Mark Katakowski; Xuguang Zheng; Feng Jiang; Thomas Rogers; Alexandra Szalad; Michael Chopp
Journal:  Cancer Invest       Date:  2010-09-27       Impact factor: 2.176

7.  The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Authors:  Paula Mussnich; Daniela D'Angelo; Vincenza Leone; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Oncol       Date:  2013-01-17       Impact factor: 6.603

8.  Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.

Authors:  Vanessa Villegas-Ruiz; Sergio Juárez-Méndez; Oscar A Pérez-González; Hugo Arreola; Lucero Paniagua-García; Miriam Parra-Melquiadez; Raúl Peralta-Rodríguez; Ricardo López-Romero; Alberto Monroy-García; Alejandra Mantilla-Morales; Guillermo Gómez-Gutiérrez; Edgar Román-Bassaure; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.

Authors:  Yuanzeng Zhu; Gang Wu; Wenfeng Yan; Han Zhan; Peichun Sun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

10.  miR-197-3p reduces epithelial-mesenchymal transition by targeting ABCA7 in ovarian cancer cells.

Authors:  Weiquan Xie; Chengyu Shui; Xiping Fang; Yuqiu Peng; Li Qin
Journal:  3 Biotech       Date:  2020-08-04       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.